4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-15-080166
Chief Executive Officer bought 850 shares at $1.73 ($1,471)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-11-13 | Purchase : show line 1 in the form | +850 | $1.73 | $1,471 | 6,300 | D |
| Open-market purchases · 850 sh · avg $1.73 · $1,471 | ||||||
Loading xslF345X03/doc4.xml…